Trials / Completed
CompletedNCT02215941
Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers
A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose Escalation Study to Characterize the Pharmacokinetics and Safety of 8% TV-45070 Ointment Following 7.5 Days of Twice Daily Topical Application in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to characterize the pharmacokinetics of TV-45070 in plasma following single and multiple-dose topical application of 8% TV-45070 ointment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TV-45070 | TV-45070 8% ointment |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Completion
- 2015-02-01
- First posted
- 2014-08-13
- Last updated
- 2021-11-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02215941. Inclusion in this directory is not an endorsement.